London, UK; Brentwood, TN, US: 20 July 2007 - In accordance with Prospectus Rule
5.2, Protherics PLC ("Protherics" or the "Company"), the international
biopharmaceutical company focused on critical care and cancer, sets out below a
list of the information that has been published or made available to the public
during the period beginning 15 July 2006 up to and including 19 July 2007.
